Infection remains a major challenge in chronic wound care, compounded by rising antimicrobial resistance, inappropriate antibiotic use, and a shrinking pipeline of new treatments. These challenges reinforce the importance of antimicrobial stewardship and raise an important question: What role can topical wound care play?

Pure hypochlorous acid (pHA) offers broad-spectrum antimicrobial activity with no known microbial resistance. Traditionally used for wound cleansing and preparation, its introduction in a sustained gel format creates new opportunities to extend its benefits beyond cleansing.

This session will explore emerging clinical evidence for Vashe® Antimicrobial Wound Gel, highlighting its potential to extend contact time, support antimicrobial activity, promote wound acidification, and facilitate debridement and healing. Through a variety of clinical cases spanning complex adult wounds to early reported uses in pediatric patients, discover how a trusted molecule in a new format may offer simple solutions to increasingly complex wound care challenges.
 

This is a non-CME event. By registering for this program, you consent to share your registration information with the program's sponsor.